Healthy subject M54.5 R52 M17 M16
Conditions
Interventions
Group 1: Healthy subject, osteoartrhitis, chronic low back pain and chronic widespread pain.
Brain-derived neurotrophic factor. This will be measured from serum samples by the method of enzyme-linked
depression and anxiety (HADS and BDI-II)
Sponsors
Medizinische Hochschule Hannover
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Diagnosis of osteoarthritis, chronic low back pain and chronic widespread pain; on the VAS the pain should be a minimum of 4; patients need to be between 18- 70 years; patients need to be able to talk and write German fluently
Exclusion criteria
Exclusion criteria: pregnancy, lactation period, cancer, cardiac anomaly, depression, diabetis, acute or inflammatory ailment, new injury; healthy patients should not have chronic pain
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| brain-derived neurotrophic factor. This will be measured from serum samples by the method of enzyme-linked immunosorbent (ELISA) assay. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body composition, Pain intensity (visual analogue scale), fatigue (visual analogue scale). Health related quality of life will be measured by Short-Form-12. Mood related disorders will be measured by Beck's depression inventory and Hospital and anxiety depression scale, Sleep related quality will be measured by Epworth sleepiness scaleand Pittsburgh Sleep quality. These all parameters/questionnaires will be measured once on recuritment day. | — |
Countries
Germany
Contacts
Public ContactDominique Dimmek
Rehabilitationsmedizin MHH
Outcome results
None listed